Dimension Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Dimension Therapeutics, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $3.70 per share as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2017-11-06
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.70.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.55.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.21.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.14.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2017-09-30 | $3.70 10-Q · filed 2017-11-06 |
| 2017-06-30 | $3.55 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.21 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.14 10-K · filed 2017-03-09 |
| 2016-09-30 | $2.92 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.50 10-Q · filed 2016-08-11 |
| 2016-03-31 | $2.07 10-Q · filed 2016-05-12 |
| 2015-12-31 | $1.35 10-K · filed 2016-03-24 |
| 2015-09-30 | $1.24 10-Q · filed 2015-12-04 |